# Northern Trust Corp: financial statements, quarterly

NTRS · Nasdaq · CIK 73124 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ntrs.md) · [Financials](/companies/ntrs/financials.md) · [Filings](/companies/ntrs/filings.md) · [Insiders](/companies/ntrs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ntrs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,090 d](/filings/0000073124-26-000016.md) | [1,143](/filings/0000073124-25-000187.md) | [1,166](/filings/0000073124-25-000235.md) | [1,197](/filings/0000073124-25-000247.md) | [1,222 d](/filings/0000073124-26-000016.md) | [1,214](/filings/0000073124-26-000035.md) | [1,231](/filings/0000073124-26-000047.md) | [1,266](/filings/0000073124-26-000066.md) | [1,307 d](/filings/0000073124-26-000016.md) | [1,341](/filings/0000073124-26-000035.md) | [1,350](/filings/0000073124-26-000047.md) | [1,373](/filings/0000073124-26-000066.md) |
| Interest expense | $m | [1,717 d](/filings/0000073124-24-000073.md) | [1,918](/filings/0000073124-24-000159.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [32.7 d](/filings/0000073124-26-000016.md) | [75.9](/filings/0000073124-25-000187.md) | [278](/filings/0000073124-25-000235.md) | [136](/filings/0000073124-25-000247.md) | [139 d](/filings/0000073124-26-000016.md) | [129](/filings/0000073124-26-000035.md) | [144](/filings/0000073124-26-000047.md) | [162](/filings/0000073124-26-000066.md) | [168 d](/filings/0000073124-26-000016.md) | [175](/filings/0000073124-26-000035.md) | [273](/filings/0000073124-26-000047.md) | [154](/filings/0000073124-26-000066.md) |
| Net income | $m | [113 d](/filings/0000073124-26-000016.md) | [215](/filings/0000073124-25-000247.md) | [896](/filings/0000073124-25-000247.md) | [465](/filings/0000073124-25-000247.md) | [455 d](/filings/0000073124-26-000016.md) | [392](/filings/0000073124-26-000066.md) | [421](/filings/0000073124-26-000066.md) | [458](/filings/0000073124-26-000066.md) | [466 d](/filings/0000073124-26-000016.md) | [526](/filings/0000073124-26-000066.md) | [792](/filings/0000073124-26-000066.md) | [643](/filings/0000073124-26-000066.md) |
| Diluted EPS | $ per share | not reported | [0.96](/filings/0000073124-25-000187.md) | [4.34](/filings/0000073124-25-000235.md) | [2.22](/filings/0000073124-25-000247.md) | not reported | [1.90](/filings/0000073124-26-000035.md) | [2.13](/filings/0000073124-25-000235.md) | [2.29](/filings/0000073124-25-000247.md) | not reported | [2.71](/filings/0000073124-26-000035.md) | not reported | not reported |
| Basic EPS | $ per share | not reported | [0.96](/filings/0000073124-25-000187.md) | [4.35](/filings/0000073124-25-000235.md) | [2.23](/filings/0000073124-25-000247.md) | not reported | [1.91](/filings/0000073124-26-000035.md) | [2.14](/filings/0000073124-25-000235.md) | [2.30](/filings/0000073124-25-000247.md) | not reported | [2.72](/filings/0000073124-26-000035.md) | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | [151](/filings/0000073124-26-000016.md) | [156](/filings/0000073124-24-000159.md) | [157](/filings/0000073124-24-000206.md) | [156](/filings/0000073124-24-000257.md) | [156](/filings/0000073124-26-000016.md) | [165](/filings/0000073124-25-000187.md) | [172](/filings/0000073124-25-000235.md) | [170](/filings/0000073124-25-000247.md) | [177](/filings/0000073124-26-000066.md) | [175](/filings/0000073124-26-000035.md) | [179](/filings/0000073124-26-000047.md) | [167](/filings/0000073124-26-000066.md) |
| Total liabilities | $bn | [139](/filings/0000073124-25-000105.md) | [144](/filings/0000073124-24-000159.md) | [144](/filings/0000073124-24-000206.md) | [143](/filings/0000073124-24-000257.md) | [143](/filings/0000073124-26-000016.md) | [152](/filings/0000073124-25-000187.md) | [159](/filings/0000073124-25-000235.md) | [157](/filings/0000073124-25-000247.md) | [164](/filings/0000073124-26-000066.md) | [162](/filings/0000073124-26-000035.md) | [166](/filings/0000073124-26-000047.md) | [154](/filings/0000073124-26-000066.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [11.9](/filings/0000073124-26-000016.md) | [12.1](/filings/0000073124-25-000247.md) | [12.7](/filings/0000073124-25-000247.md) | [12.7](/filings/0000073124-25-000247.md) | [12.8](/filings/0000073124-26-000066.md) | [12.9](/filings/0000073124-26-000066.md) | [12.9](/filings/0000073124-26-000066.md) | [13.0](/filings/0000073124-26-000066.md) | [13.0](/filings/0000073124-26-000066.md) | [13.0](/filings/0000073124-26-000066.md) | [13.4](/filings/0000073124-26-000066.md) | [13.4](/filings/0000073124-26-000066.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,803 d](/filings/0000073124-26-000016.md) | [(1,453)](/filings/0000073124-25-000187.md) | [2,990 d](/filings/0000073124-25-000235.md) | [611 d](/filings/0000073124-25-000247.md) | [(2,635) d](/filings/0000073124-26-000016.md) | [2,750](/filings/0000073124-26-000035.md) | [1,870 d](/filings/0000073124-26-000047.md) | [526 d](/filings/0000073124-26-000066.md) | [388 d](/filings/0000073124-26-000016.md) | [(320)](/filings/0000073124-26-000035.md) | [(64.9) d](/filings/0000073124-26-000047.md) | [1,825 d](/filings/0000073124-26-000066.md) |
| Capital expenditure | $m | [63.8 d](/filings/0000073124-26-000016.md) | [14.3](/filings/0000073124-25-000187.md) | [20.8 d](/filings/0000073124-25-000235.md) | [25.7 d](/filings/0000073124-25-000247.md) | [40.7 d](/filings/0000073124-26-000016.md) | [12.4](/filings/0000073124-26-000035.md) | [12.4 d](/filings/0000073124-26-000047.md) | [16.4 d](/filings/0000073124-26-000066.md) | [32.8 d](/filings/0000073124-26-000016.md) | [9.4](/filings/0000073124-26-000035.md) | [25.4 d](/filings/0000073124-26-000047.md) | [22.2 d](/filings/0000073124-26-000066.md) |
| Dividends paid | $m | [154 d](/filings/0000073124-26-000016.md) | [154](/filings/0000073124-25-000187.md) | [152 d](/filings/0000073124-25-000235.md) | [149 d](/filings/0000073124-25-000247.md) | [148 d](/filings/0000073124-26-000016.md) | [146](/filings/0000073124-26-000035.md) | [144 d](/filings/0000073124-26-000047.md) | [152 d](/filings/0000073124-26-000066.md) | [150 d](/filings/0000073124-26-000016.md) | [149](/filings/0000073124-26-000035.md) | [147 d](/filings/0000073124-26-000047.md) | [160 d](/filings/0000073124-26-000066.md) |
| Share repurchases | $m | [146 d](/filings/0000073124-26-000016.md) | [132](/filings/0000073124-25-000187.md) | [251 d](/filings/0000073124-25-000235.md) | [301 d](/filings/0000073124-25-000247.md) | [254 d](/filings/0000073124-26-000016.md) | [287](/filings/0000073124-26-000035.md) | [339 d](/filings/0000073124-26-000047.md) | [277 d](/filings/0000073124-26-000066.md) | [370 d](/filings/0000073124-26-000016.md) | [359](/filings/0000073124-26-000035.md) | [351 d](/filings/0000073124-26-000047.md) | [352 d](/filings/0000073124-26-000066.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [209](/filings/0000073124-24-000159.md) | [208](/filings/0000073124-24-000206.md) | [207](/filings/0000073124-24-000257.md) | [205](/filings/0000073124-25-000187.md) | [204](/filings/0000073124-25-000235.md) | [201](/filings/0000073124-25-000247.md) | [196](/filings/0000073124-26-000035.md) | [193](/filings/0000073124-26-000047.md) | [191](/filings/0000073124-26-000066.md) | [187](/filings/0000073124-26-000035.md) | [185](/filings/0000073124-26-000047.md) | [183](/filings/0000073124-26-000066.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 181,117,806 at 2026-09-30, from the cover of the [10-Q filed 2026-10-29](/filings/0000073124-26-000066.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 16:40 ET. No prices; not investment advice.